Libero Thera
Nihombashi-hamacho
About Libero Thera
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Last round: Series Unknown (Aug 2024)
- Website: liberothera.com
- Phone: +81 145-633-4725
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/libero-thera-8802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.